R. Zemel

发表

Development and application of a high‐throughput microneutralization assay: lack of xenotropic murine leukemia virus–related virus and/or murine leukemia virus detection in blood donors

W. Heneine, Y. Ikeda, G. Simmons, 2012, Transfusion.

Differences in the biochemical properties of esterolytic antibodies correlate with structural diversity.

Dan S. Tawfik, Z. Eshhar, D. Schindler, 1994, Molecular immunology.

Crystal structure of a catalytic antibody Fab with esterase-like activity.

Dan S. Tawfik, J. Navaza, B. Golinelli‐Pimpaneau, 1994, Structure.

Simple method for selecting catalytic monoclonal antibodies that exhibit turnover and specificity.

Dan S. Tawfik, R. Arad-Yellin, Z. Eshhar, 1990, Biochemistry.

Mechanism of inactivation of a catalytic antibody by p-nitrophenyl esters.

B. Golinelli‐Pimpaneau, Z. Eshhar, J. Charbonnier, 1997, European journal of biochemistry.

A Two‐Step Strategy for Structure–Activity Relationship Studies of N‐Methylated Aβ42 C‐Terminal Fragments as Aβ42 Toxicity Inhibitors

G. Bitan, Huiyuan Li, D. Lopes, 2012, ChemMedChem.

Mechanistic investigation of the inhibition of Abeta42 assembly and neurotoxicity by Abeta42 C-terminal fragments.

G. Bitan, B. Urbanc, G. Benedek, 2010, Biochemistry.

Mechanistic investigation of the inhibition of Abeta42 assembly and neurotoxicity by Abeta42 C-terminal fragments.

G. Bitan, B. Urbanc, G. Benedek, 2010, Biochemistry.

Mechanistic Investigation of the Inhibition of A#42 Assembly and Neurotoxicity by A#42 C-terminal Fragments

G. Bitan, B. Urbanc, Huiyuan Li, 2011 .